Ignite Creation Date:
2025-12-25 @ 2:46 AM
Ignite Modification Date:
2026-01-06 @ 2:41 PM
Study NCT ID:
NCT00628433
Status:
COMPLETED
Last Update Posted:
2011-06-14
First Post:
2008-02-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
Sponsor:
Harbor Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HE3286-0301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Nanette Onizuka-Handa, Sr. Vice President, Regulatory Affairs and Quality
Old Organization:
Hollis-Eden Pharmaceuticals